According to flow cytometry data, the proportion of CD14++CD16 macrophages from BALF in the subgroup of patients with pulmonary sarcoidosis was lower than in that in healthy people, and the proportion of CD14++CD16+ in the subgroup was higher [27]. This evidence concerns the gene CD14 and pulmonary sarcoidosis.